Risk factors for Mortality in Patients with COVID-19 in Cuernavaca-Morelos
- 1 September 2025
- journal article
- Published by Bentham Science Publishers Ltd. in Current Respiratory Medicine Reviews
- Vol. 21 (4) , 383-391
Abstract
Background: The world changed in December 2019 due to respiratory tract infection cases, initially of unknown etiology, later known as COVID-19. Objective: This study aimed to determine the factors and comorbidities associated with mortality from COVID-19 in Mexico. Methods: It was a cross-sectional and observational prospective study of patients treated at an IMSS (Mexican Institute of Social Security) Hospital in Morelos with a confirmed diagnosis of COVID-19. Logistic regression models and survival analyses were developed to identify factors associated with mortality risk. Results: 3,965 patients were analyzed, with most deaths occurring in men. The mortality risks were higher in men who were older than 50 years. The most significant associations were: age older than 80 years (HR:3.17), endotracheal intubation (HR:1.54), dyspnea (HR: 13.55), and polypnea (HR:1.54). Conclusion: The risk of death in this population was high, considering the absence of primary protective measures at the beginning of the pandemic and the lack of consistency in using personal protection elements.Keywords
This publication has 55 references indexed in Scilit:
- Geriatrics and COVID-192021
- Screening and Severity of Coronavirus Disease 2019 (COVID-19) in Children in Madrid, SpainJAMA Pediatrics, 2021
- Chronic comorbidities and clinical outcomes in patients with and without COVID-19: a large population-based study using national administrative healthcare open data of MexicoInternal and Emergency Medicine, 2021
- Obesity aggravates COVID‐19: A systematic review and meta‐analysisJournal of Medical Virology, 2020
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington StateJAMA, 2020
- A Bold Response to the COVID-19 PandemicJAMA, 2020
- Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, ChinaCurrent Medical Science, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic ToolsVirologica Sinica, 2020
- Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, ChinaJournal of Medical Virology, 2020